Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The START Clinic for Mood and Anxiety Disorders is a Toronto-based specialized healthcare facility and clinical research center focused on the assessment and treatment of complex psychiatric conditions. Led by Dr. Martin Katzman, the clinic integrates tertiary-level clinical care with cutting-edge research, participating in numerous Phase 2 through Phase 4 clinical trials for mood, anxiety, and attention disorders. Their multidisciplinary approach combines pharmacological treatments with psychological interventions such as Cognitive Behavioral Therapy (CBT) and Mindfulness-based therapies. The clinic serves as a significant site for psychiatric drug development and academic research in Canada, collaborating frequently with major pharmaceutical sponsors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on START Clinic for Mood and Anxiety Disorders.